This study shows that GSTM1 null genotype was associated with significantly increased BC risk (OR 1.85, 95 % CI 1.30–2.62), while GSTT1 null genotype with the risk reduction (OR 0.50, 95 % CI 0.31–0.81). This evidence concerns the gene GSTM1 and breast cancer.